Ferring Pharmaceuticals Inc.
Ferring Pharmaceuticals Inc., a global biopharmaceutical company, is headquartered in the United States and operates extensively across Europe, Asia, and Latin America. Founded in 1950, Ferring has established itself as a leader in reproductive health, urology, and gastroenterology, focusing on innovative therapies that address unmet medical needs. The company is renowned for its core products, including hormone therapies and treatments for various gastrointestinal disorders, which are distinguished by their patient-centric approach and commitment to research and development. Ferring's dedication to advancing healthcare has positioned it as a notable player in the biopharmaceutical industry, with significant achievements in clinical research and a robust pipeline of therapies aimed at improving patient outcomes.
DitchCarbon Score
How does Ferring Pharmaceuticals Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ferring Pharmaceuticals Inc.'s score of 28 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Ferring Pharmaceuticals Inc.'s reported carbon emissions
Ferring Pharmaceuticals Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their current carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company is likely engaged in industry-standard climate commitments, which may include initiatives aimed at reducing environmental impact and enhancing sustainability practices. As the pharmaceutical sector increasingly focuses on climate action, Ferring Pharmaceuticals may be developing strategies to align with global climate goals, although specific details are not provided.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ferring Pharmaceuticals Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
